# Fluoxetine in KCNC1-related Disorder

> **NCT06341127** · NA · COMPLETED · sponsor: **Holland Bloorview Kids Rehabilitation Hospital** · enrollment: 1 (actual)

## Conditions studied

- KCNC1 Related Disorder
- Genetic Disease
- Rare Diseases

## Interventions

- **DRUG:** Fluoxetine

## Key facts

- **NCT ID:** NCT06341127
- **Lead sponsor:** Holland Bloorview Kids Rehabilitation Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-17
- **Primary completion:** 2024-11-28
- **Final completion:** 2024-11-28
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2025-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06341127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06341127, "Fluoxetine in KCNC1-related Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06341127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*